newsfilter
← Latest News
Business Wire·

Acorda Therapeutics Receives Nasdaq Listing Determination Letter and Plans to Request a Hearing

Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that it was notified by the Listing Qualifications Staff of The Nasdaq Stock Market LLC that, due to the Company's common stock not having regained compliance